CD59 and COVID-19: This included an upregulation of SPM from the DHA, n-3 docosapentaenoic acid (DPA), and eicosapentaenoic acid bioactive metabolomes in patients with COVID-19, such as DHA-derived maresin conjugates in tissue regeneration (MCTR) 3, protectin conjugates in tissue regeneration (PCTR) 3, and RvD6, and n-3 DPA-derived RvD5n-3 DPA and PD1n-3 DPA.